The stock of Concord Biotech has been in a sideways trend so far this week after losing nearly 13 per cent last week. It is now consolidating above a strong support band of ₹1,750-1,775. We expect the stock to gain positive momentum on the back of this and see a rally in the short term. The initial rebound can take the stock to ₹1,960, a minor hurdle. Around this price point, there might be some sideways crawl or a minor dip to ₹1,920. After this, the stock can see a rally to ₹2,140. So, traders can buy the stock now at ₹1,797 and ₹1,760. Stop-loss can be ₹1,720. When the contract touches ₹1,960, revise the stop-loss to ₹1,880. Trail the stop-loss to ₹1,920 when the stock hits ₹2,030. Exit at ₹2,140.

Video Credit: Businessline

Note: The recommendations are based on technical analysis. There is a risk of loss in trading.

Published on June 27, 2025